SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

younger kidney cancer survivors are more susceptible to heart problems.

2.

Cancer Patients' Depression May Be Helped by Psilocybin.

3.

WHO launches plan for free child cancer medicines

4.

For older patients with Hodgkin lymphoma, novel regimens produce high response rates.

5.

High weight and obesity are associated with poor outcomes in leukemia treatment.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot